Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.7 and B.1.351 variants
were first identified in the United Kingdom and South Africa, respectively, and have since …

Convergent evolution of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 lineages has led to the
emergence of several new subvariants, including BA.2.75.2, BA.4.6. and BQ.1.1. The …

It is of paramount importance to evaluate the prevalence of both asymptomatic and symptomatic
cases of SARS-CoV-2 infection and their differing antibody response profiles. Here, we …

Severe COVID‐19 is characterized by lung abnormalities, including the presence of syncytial
pneumocytes. Syncytia form when SARS‐CoV‐2 spike protein expressed on the surface of …

Background The Oise department in France has been heavily affected by COVID-19 in early
2020. Methods Between 30 March and 4 April 2020, we conducted a retrospective closed …

Coordinated local mucosal and systemic immune responses following severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection either protect against coronavirus …

Influenza A, B and C viruses (IAV, IBV and ICV, respectively) circulate globally and infect
humans, with IAV and IBV causing the most severe disease. CD8 + T cells confer cross-…

Background The serologic response of individuals with mild forms of SARS-CoV-2 infection
is poorly characterized. Methods Hospital staff who had recovered from mild forms of PCR-…

Background Children’s role in SARS-CoV-2 epidemiology remains unclear. We investigated
an initially unnoticed SARS-CoV-2 outbreak linked to schools in northern France, beginning …

Disclosures: C. Planchais reported a patent to PCT/EP2022/058777 licensed (SpikImm). I.
Fernández reported a patent to PCT/EP2022/058777 licensed (SpikImm). T. Bruel reported a …